Browsing: Psychedelics

A case of mistaken identity and an experimental psychedelic compound give two best friends telepathic powers, setting off a bizarre chain of events involving talking cats…

MDMA gummies. DMT vapes. Mushroom chocolates sold in smoke shops halfway around the world. Long before regulators figured out what legal psychedelics might look like, an…

Players Can Invest, With StringsLast To The Party The league pulled marijuana off its banned list in the new players’ agreement. In the same document, it…

The clinical evidence is real. The valuations are not. Compass Pathways: $560 million market cap, zero revenue. MindMed: up to $2 billion, zero revenue. Even Ozempic…

The idea may sound strange: a tobacco plant producing compounds like psilocybin or DMT. Sounds strange, right? You’ve probably never heard of it. But beyond the…

President Trump signed an executive order on April 18 directing the FDA to fast-track review of psychedelic therapies and committing $50 million to ibogaine research. The…

One of the biggest myths about drugs is that their use is new, purely recreational, or a way to escape reality. “In the good old days,…

The DoubleBlind Guide to Psychedelics: A Road Map to Tripping, Microdosing, and Beyond is available for pre-order now and hits shelves April 14, bringing together seven…

In industries built on culture as much as commerce, the right storyteller can shape how your brand is understood. Cannabis and psychedelics companies do not simply…

For the first time, Latin America will host a gathering of the world’s leading minds in psychedelics, mental health, and longevity. On October 8–10, Buenos Aires…